BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 7371360)

  • 1. Relationship between saliva salicylate concentration and free or total salicylate concentration in serum of children with juvenile rheumatoid arthritis.
    Levy G; Procknal JA; Olufs R; Pachman LM
    Clin Pharmacol Ther; 1980 May; 27(5):619-27. PubMed ID: 7371360
    [No Abstract]   [Full Text] [Related]  

  • 2. Salivary of blood specimen for evaluation of drug concentration in rheumatoid arthritis.
    Bird HA; Pickup ME
    Clin Rheumatol; 1985 Jun; 4(2):220. PubMed ID: 4006391
    [No Abstract]   [Full Text] [Related]  

  • 3. Blood and saliva salicylate measurement in the monitoring of salicylate therapy.
    Pérez-Mateo M; Erill S; Cabezas R
    Int J Clin Pharmacol Biopharm; 1977 Mar; 15(3):113-5. PubMed ID: 844929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic monitoring of salicylate therapy in children with juvenile rheumatoid arthritis.
    Pachman LM; Olufs R; Procknal JA; Levy G
    Arthritis Rheum; 1979 Aug; 22(8):826-31. PubMed ID: 465097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Salicylate therapy in juvenile rheumatoid arthritis. Dose, serum level, and toxicity.
    Doughty RA; Giesecke L; Athreya B
    Am J Dis Child; 1980 May; 134(5):461-3. PubMed ID: 7377152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlations between transaminase concentrations and serum salicylate concentration in juvenile rheumatoid arthritis.
    Miller JJ; Weissman DB
    Arthritis Rheum; 1976; 19(1):115-8. PubMed ID: 1252262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolism of salicylate during chronic aspirin therapy.
    Rumble RH; Brooks PM; Roberts MS
    Br J Clin Pharmacol; 1980 Jan; 9(1):41-5. PubMed ID: 7356892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Corticosteroids-salicylate interaction in a case of juvenile rheumatoid arthritis.
    Koren G; Roifman C; Gelfand E; Lavi S; Suria D; Stein L
    Ther Drug Monit; 1987 Jun; 9(2):177-9. PubMed ID: 3617157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum protein binding and salivary secretion of salicylic acid in man.
    Kaneo Y; Nishikawa A; Fukasawa K; Kato Y
    Chem Pharm Bull (Tokyo); 1980; 28(4):1251-7. PubMed ID: 7418112
    [No Abstract]   [Full Text] [Related]  

  • 10. Concentration dependent plasma protein binding of salicylate in rheumatoid patients.
    Ekstrand R; Alvan G; Borga O
    Clin Pharmacokinet; 1979; 4(2):137-43. PubMed ID: 378501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of salivary salicylate data to biopharmaceutical studies of salicylates.
    Graham G; Rowland M
    J Pharm Sci; 1972 Aug; 61(8):1219-22. PubMed ID: 5050370
    [No Abstract]   [Full Text] [Related]  

  • 12. Aspirin-induced hepatotoxicity in juvenile rheumatoid arthritis. A prospective study.
    Athreya BH; Moser G; Cecil HS; Myers AR
    Arthritis Rheum; 1975; 18(4):347-52. PubMed ID: 1156454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Micromeasurement of plasma salicylate in arthritic children.
    Jacobs JC; Pesce M
    Arthritis Rheum; 1978; 21(1):129-32. PubMed ID: 623682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Value of monitoring plasma salicylate levels in treating juvenile rheumatoid arthritis. Observations in 42 cases.
    Bardare M; Cislaghi GU; Mandelli M; Sereni F
    Arch Dis Child; 1978 May; 53(5):381-5. PubMed ID: 666351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical pharmacokinetics of the salicylates.
    Needs CJ; Brooks PM
    Clin Pharmacokinet; 1985; 10(2):164-77. PubMed ID: 3888490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Free versus bound salicylate concentration in adults and children with chronic inflammatory joint disease: serum albumin and other potential factors affecting the levels.
    Costello PB; Green FA; Jung CY
    Arthritis Rheum; 1982 Jan; 25(1):32-7. PubMed ID: 7066035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dosage of salicylates for children with juvenile rheumatoid arthritis. A preliminary report.
    Mäkelä AL; Tryänä T; Haapasaari J
    Scand J Rheumatol; 1975; 4(4):250-2. PubMed ID: 1198081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decrease of in vitro serum protein binding of salicylate in rheumatoid arthritis.
    Netter P; Monot C; Stalars MC; Mur JM; Royer RJ; Faure G; Pourel J; Martin J; Gaucher A
    Eur J Drug Metab Pharmacokinet; 1984; 9(2):109-16. PubMed ID: 6745302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Children with juvenile rheumatoid arthritis treated with salicylates for 15 days, with daily serum salicylate determinations.
    Calabro JJ; Brunstein SL; Staley HL
    Scand J Rheumatol; 1976; 5(4):251-2. PubMed ID: 1006215
    [No Abstract]   [Full Text] [Related]  

  • 20. Interaction between valproic acid and aspirin in epileptic children: serum protein binding and metabolic effects.
    Orr JM; Abbott FS; Farrell K; Ferguson S; Sheppard I; Godolphin W
    Clin Pharmacol Ther; 1982 May; 31(5):642-9. PubMed ID: 6804150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.